BiotechTube
Huadong Medicine (HD Medicine)

Huadong Medicine (HD Medicine)

000963.SZ
Hangzhou, China· Est. 1993

Huadong Medicine Co., Ltd. is a major Chinese pharmaceutical enterprise that develops, manufactures, and markets both innovative and generic drugs. The company operates through multiple subsidiaries and has built a diversified portfolio spanning oncology, cardiovascular, diabetes, and other therapeutic areas. With its public listing and substantial market valuation, Huadong Medicine represents one of China's significant pharmaceutical investment opportunities.

ehd.com.cn

000963.SZ · Stock Price

USD 33.87+0.11 (+0.33%)
Market Cap: $8.7B

Historical price data

AI Company Overview

Huadong Medicine Co., Ltd. is a major Chinese pharmaceutical enterprise that develops, manufactures, and markets both innovative and generic drugs. The company operates through multiple subsidiaries and has built a diversified portfolio spanning oncology, cardiovascular, diabetes, and other therapeutic areas. With its public listing and substantial market valuation, Huadong Medicine represents one of China's significant pharmaceutical investment opportunities.

Biotech

Technology Platform

Diversified pharmaceutical platform developing and manufacturing both innovative and generic drugs across multiple therapeutic areas.

Funding History

1
IPOUndisclosedDec 15, 1999

Opportunities

Well-positioned to capitalize on China's growing pharmaceutical market, aging population demographics, and government support for domestic pharmaceutical innovation and manufacturing capabilities.

Risk Factors

Faces regulatory uncertainties in China's evolving healthcare policy environment, pricing pressures from government reforms, and intense competition from both domestic and international pharmaceutical companies.

Competitive Landscape

Operates in China's competitive pharmaceutical landscape alongside major domestic players like Jiangsu Hengrui Medicine and international companies, with differentiation likely based on product portfolio, manufacturing capabilities, and market access strategies.